194 related articles for article (PubMed ID: 29360580)
1. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
[TBL] [Abstract][Full Text] [Related]
2. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
[TBL] [Abstract][Full Text] [Related]
3. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis.
Vouk K; Hevir N; Ribić-Pucelj M; Haarpaintner G; Scherb H; Osredkar J; Möller G; Prehn C; Rižner TL; Adamski J
Hum Reprod; 2012 Oct; 27(10):2955-65. PubMed ID: 22859507
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
5. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
[TBL] [Abstract][Full Text] [Related]
6. Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes.
Ziegler D; Strom A; Straßburger K; Knebel B; Bönhof GJ; Kotzka J; Szendroedi J; Roden M;
Diabetologia; 2021 Feb; 64(2):458-468. PubMed ID: 33084971
[TBL] [Abstract][Full Text] [Related]
7. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
8. Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults.
Semba RD; Gonzalez-Freire M; Moaddel R; Sun K; Fabbri E; Zhang P; Carlson OD; Khadeer M; Chia CW; Salem N; Ferrucci L
J Clin Endocrinol Metab; 2018 Sep; 103(9):3331-3339. PubMed ID: 29947780
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
11. Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Profiling of Plasma from Melioidosis Patients Using UHPLC-QTOF MS Reveals Novel Biomarkers for Diagnosis.
Lau SK; Lee KC; Lo GC; Ding VS; Chow WN; Ke TY; Curreem SO; To KK; Ho DT; Sridhar S; Wong SC; Chan JF; Hung IF; Sze KH; Lam CW; Yuen KY; Woo PC
Int J Mol Sci; 2016 Feb; 17(3):307. PubMed ID: 26927094
[TBL] [Abstract][Full Text] [Related]
13. Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients.
Ho HY; Chen YH; Lo CJ; Tang HY; Chang SW; Fan CM; Ho YH; Lin G; Chiu CY; Lin CM; Cheng ML
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474739
[TBL] [Abstract][Full Text] [Related]
14. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.
Cheng ML; Wang CH; Shiao MS; Liu MH; Huang YY; Huang CY; Mao CT; Lin JF; Ho HY; Yang NI
J Am Coll Cardiol; 2015 Apr; 65(15):1509-20. PubMed ID: 25881932
[TBL] [Abstract][Full Text] [Related]
15. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
[TBL] [Abstract][Full Text] [Related]
17. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
18. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
19. Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics.
Marksteiner J; Oberacher H; Humpel C
J Alzheimers Dis; 2019; 68(2):583-589. PubMed ID: 30814361
[TBL] [Abstract][Full Text] [Related]
20. Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.
Tang HY; Chiu DT; Lin JF; Huang CY; Chang KH; Lyu RK; Ro LS; Kuo HC; Cheng ML; Chen CM
Sci Rep; 2017 Aug; 7(1):8140. PubMed ID: 28811529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
